Molecular Minimal Disease in Remission Predicts AML Relapse

WEDNESDAY, March 28, 2018 -- The detection of molecular minimal residual disease is associated with increased relapse rates in acute myeloid leukemia (AML), according to a study published in the March 29 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news